Advertisement
Canada Markets close in 2 hrs 26 mins

  • S&P/TSX

    22,305.90
    -69.93 (-0.31%)
     

  • S&P 500

    5,215.26
    +1.18 (+0.02%)
     

  • DOW

    39,479.66
    +91.90 (+0.23%)
     

  • CAD/USD

    0.7316
    +0.0005 (+0.0717%)
     

  • CRUDE OIL

    78.35
    -0.91 (-1.15%)
     

  • BTC-CAD

    82,574.69
    -2,310.29 (-2.72%)
     

  • CMC Crypto 200

    1,256.39
    -101.61 (-7.48%)
     

  • GOLD FUTURES

    2,374.80
    +34.50 (+1.47%)
     

  • RUSSELL 2000

    2,055.33
    -18.30 (-0.88%)
     

  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     

  • NASDAQ

    16,314.55
    -31.71 (-0.19%)
     

  • VOLATILITY

    12.73
    +0.04 (+0.32%)
     

  • FTSE

    8,433.76
    +52.41 (+0.63%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • CAD/EUR

    0.6786
    +0.0008 (+0.12%)
     
MARKETS LIVE BLOG:

STOCKS RISE AS DOW EYES GAIN FOR 8TH STRAIGHT SESSION

U.S. consumer sentiment tumbles in May as inflation, interest rate worries take hold

Stocks in play: Nuvo Pharmaceuticals Inc.

Baystreet.ca

Announced its financial and operational results for the three months ended September 30, 2019. Adjusted total revenue was $18.9 million for the three months ended September 30, 2019 compared to $5.1 million for the three months ended September 30, 2018. Adjusted EBITDA was $7.8 million for the three months ended September 30, 2019 compared to $(1.3) million for the three months ended September 30, 2018. Gross profit on total revenue was $11.3 million or 60% for the three months ended September 30, 2019 compared to a gross profit of $2.9 million or 57% for the three months ended September 30, 2018. Nuvo Pharmaceuticals Inc. shares T.NRI are trading up $0.06 at $0.53.

READ: The 5 Most Disruptive Tech Stocks Of The Year